Authors: Jade Parker, Editor
Professor Dame Sally Davies’s eighth independent report to government as Chief Medical Officer – Generation Genome – highlighted the vital role genetics and genomics will play in UK NHS healthcare and medicine. In this report she stated that cancer patients should be routinely offered DNA tests to help select the best treatments for them. Illumina, is a leading sequencing technology company and has a partnership with Genomics England working on the 100,000 Genomes Project. We recently spoke with Illumina’s Chief Scientist, David Bentley about his thoughts on the report and the implications the 100,000 Genomes Project may have for rare genetic diseases and cancer.
The UK Chief Medical Officer’s annual report 2016: Generation Genome, looks at how genomics can improve health and prevent ill-health. What are your thoughts on this report?